Jameson J S, Thomas W M, Dawson S, Wood J K, Johnstone J M
Department of Surgery, Leicester Royal Infirmary, UK.
J R Coll Surg Edinb. 1996 Oct;41(5):307-11.
The role of splenectomy in haematological disease appears to be changing. This single centre, retrospective study was carried out to document the indications for splenectomy and its outcome over a 7-year period and to compare it with the preceding 7-year period. Sixty-four patients underwent splenectomy in the study period, the main indication being idiopathic thrombocytopenic purpura. There was one post-operative death and morbidity was seen in 40 (63%) patients. Splenectomy was successful in achieving the desired aim in 51 (80%) patients. Approximately 40% fewer patients underwent splenectomy in the study period compared with the preceding 7 years despite there being an overall increase of 123 (633 vs. 540) patients treated for haematological disease in this period. The reason for this observation was the fall in the number of splenectomies performed for Hodgkin's disease and auto-immune haemolytic anaemia.
脾切除术在血液系统疾病中的作用似乎正在发生变化。本单中心回顾性研究旨在记录7年间脾切除术的适应证及其结果,并与前一个7年期间进行比较。在研究期间,64例患者接受了脾切除术,主要适应证为特发性血小板减少性紫癜。术后有1例死亡,40例(63%)患者出现并发症。51例(80%)患者的脾切除术成功实现了预期目标。与前一个7年相比,尽管在此期间接受血液系统疾病治疗的患者总数增加了123例(从540例增至633例),但研究期间接受脾切除术的患者数量减少了约40%。这一现象的原因是霍奇金病和自身免疫性溶血性贫血的脾切除例数减少。